Compound improves cardiac function in mice with genetic heart defect, MU study finds

(University of Missouri-Columbia) Congenital heart disease is the most common form of birth defect. Researchers from the University of Missouri recently found success using a drug to treat laboratory mice with one form of congenital heart disease, hypertrophic cardiomyopathy -- a weakening of the heart caused by abnormally thick muscle. By suppressing a faulty protein, the researchers reduced the thickness of the mice's heart muscles and improved their cardiac functioning.
Source: EurekAlert! - Biology - Category: Biology Source Type: news